TX-SCHUMACHER-ELECTRIC
3.11.2021 09:05:08 CET | Business Wire | Press release
Schumacher Electric Corporation, the global leader of automotive aftermarket power conversion products, has introduced its new Rugged Lithium Ion Jump Starter series to the United States and European markets. Available in 1000, 1500, 2000 and 2500 peak amps, these jump starters are powerful, portable and compact, and can safely start a dead battery in seconds. The line will be available online and in select retailers.
“Our national lithium jump starter launch times perfectly for winterization preparations as the jump starters feature pre-heating technology to warm batteries in extreme cold,” said Mickey Leech, CEO at Schumacher Electric Corporation. “It’s also the perfect holiday gift for all drivers in your family or simply the person who has it all because of its multi-use design that includes the ability to charge a variety of USB devices. As we move towards our 75th company anniversary in 2022, we will continue to bring new, innovative products to market and set Schumacher apart from its competitors.”
Key features of the Schumacher Rugged Lithium Ion Jump Starter Product Line:
Schumacher 1000 Peak Amp Rugged Lithium Ion Jump Starter
- 1000 peak amps
- 25 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 6.0L gas and 3.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 1500 Peak Amp Rugged Lithium Ion Jump Starter
- 1500 peak amps
- 35 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 8.0L gas and 6.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2000 Peak Amp Rugged Lithium Ion Jump Starter
- 2000 peak amps
- 45 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2500 Peak Amp Rugged Lithium Ion Jump Starter
- 2500 peak amps
- 50 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster
- 2.4A USB charges devices twice as fast via powered USB port
- LED area light
“We are pleased to bring top-of-the-line lithium jump starter products to market that are not only powerful but designed with ease-of-use in mind,” said Dirk Kuyckx, general manager of Schumacher Europe. “We wanted to offer a variety of products with unique features to meet the needs of all consumers and standout in a crowded market. Whether it’s a car, van, SUV, boat or recreational vehicle, our lithium jump starter has a durable rugged design with pre-boost technology for bringing even deeply discharged batteries back to life.”
About Schumacher Electric Corporation
Schumacher Electric Corporation is known for industry-leading innovation, an unwavering commitment to quality, and providing feature-rich products that represent a remarkable value and price. For nearly 75 years, Schumacher has been powering lifestyles with a legacy centered on delivering product excellence and exceptional service to customers with a broad range of needs and experience levels. Put your trust in a Schumacher.
To learn more visit: www.schumacherelectric.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005155/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom